{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T22:17:01Z","timestamp":1769120221220,"version":"3.49.0"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>This paper reports a rare case of a 4-year-old male child with acute lymphoblastic leukemia (ALL) presenting initially with bone marrow necrosis (BMN) as the chief clinical manifestation. The child sought medical attention due to fever, bone pain, and fatigue. Laboratory tests indicated pancytopenia. Initial bone marrow cytomorphology examination revealed disrupted cellular architecture, suggesting possible BMN, and single-site flow cytometry detected no definitive abnormalities, highlighting the diagnostic complexity caused by BMN. Through multi-site bone marrow aspiration and biopsy, the diagnosis was ultimately confirmed as common B-cell ALL (common-B-ALL). Treatment followed the South China Children\u2019s Cancer Collaborative Group SCCCG-ALL-2023 protocol, incorporating blinatumomab immunotherapy based on risk stratification. The child responded well to treatment and is currently in the maintenance chemotherapy phase, with minimal residual disease (MRD) monitoring consistently indicating complete remission. This case emphasizes the importance of early recognition of rare presentations like BMN-onset in pediatric ALL, the necessity of multi-site bone marrow examination, and the crucial role of individualized treatment strategies.<\/jats:p>","DOI":"10.3389\/fonc.2026.1737632","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T05:14:40Z","timestamp":1769058880000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Acute lymphoblastic leukemia with bone marrow necrosis as the first clinical manifestation: a pediatric case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Liangwu","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianren","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanghui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1400972","article-title":"Acute lymphoblastic leukemia in children","volume":"373","author":"Hunger","year":"2015","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e9565","DOI":"10.7759\/cureus.9565","article-title":"Unexpected and deadly: three cases of bone marrow necrosis","volume":"12","author":"Chan","year":"2020","journal-title":"Cureus"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(20000415)88:8<1769::AID-CNCR3>3.0.CO;2-H","article-title":"Bone marrow necrosis","volume":"88","author":"Janssens","year":"2000","journal-title":"Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830290408","article-title":"Extensive bone marrow necrosis in patients with cancer and tumor necrosis factor activity in plasma","volume":"29","author":"Knupp","year":"1988","journal-title":"Am J Hematol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24074","article-title":"Bone marrow necrosis in acute leukemia: Clinical characteristic and outcome","volume":"90","author":"Talha","year":"2015","journal-title":"Am J Hematol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000001532","article-title":"Bone marrow necrosis in a patient following blinatumomab therapy","volume":"42","author":"Yarali","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1611701","article-title":"Blinatumomab in pediatric B-acute lymphoblastic leukemia","volume":"16","author":"Cheng","year":"2025","journal-title":"Front Immunol"},{"key":"B8","first-page":"47","article-title":"Necrosis of the bone marrow with fat embolism in sickle cell anemia","volume":"17","author":"Wade","year":"1941","journal-title":"Am J Pathol"},{"key":"B9","first-page":"3","article-title":"Research progress of BMN","volume":"47","author":"Pan","year":"2018","journal-title":"Chongqing Med Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(76)90752-X","article-title":"Bone marrow necrosis","volume":"60","author":"Kiraly","year":"1976","journal-title":"Am J Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2024.285643","article-title":"Relapsed childhood T-cell acute lymphoblastic leukemia and lymphoblastic lymphoma","volume":"110","author":"Hughes","year":"2025","journal-title":"Haematologica"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e24835","DOI":"10.7759\/cureus.24835","article-title":"Serum tumor necrosis factor-alpha levels in acute leukemia and its prognostic significance","volume":"14","author":"Verma","year":"2022","journal-title":"Cureus"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200303000-00005","article-title":"Prognostic significance of the TEL-AML1 fusion gene in pediatric acute lymphoblastic leukemia in Turkey","volume":"25","author":"Ozbek","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"B14","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V90.12.4933","article-title":"Incidence of TEL\/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse","volume":"90","author":"Harbott","year":"1997","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1756-8722-1-17","article-title":"Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study","volume":"1","author":"Mosad","year":"2008","journal-title":"J Hematol Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.12122\/j.issn.1673-4254.2020.02.17","article-title":"Prognostic significance and risk factors of minimal residual disease \u22651% on 19th day of induction chemotherapy in children with acute lymphoblastic leukemia","volume":"40","author":"Yu","year":"2020","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401256","article-title":"TEL\/AML1 positivity in childhood ALL: average or better prognosis? Czech Paediatric Haematology Working Group","volume":"13","author":"Zuna","year":"1999","journal-title":"Leukemia"},{"key":"B18","doi-asserted-by":"publisher","first-page":"904","DOI":"10.3390\/ijms21030904","article-title":"Impact and intricacies of bone marrow microenvironment in B-cell lymphomas: from biology to therapy","volume":"21","author":"Sircar","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B19","first-page":"3","article-title":"Clinical analysis of 15 cases of acute leukemia with BMN as the first manifestation","volume":"30","author":"Wang","year":"2016","journal-title":"J Chin Pract Diagnosis Ther"},{"key":"B20","doi-asserted-by":"publisher","first-page":"8889850","DOI":"10.1155\/2020\/8889850","article-title":"Extensive bone marrow necrosis: A rare presentation of acute lymphoblastic leukaemia","volume":"2020","author":"Ranathunga","year":"2020","journal-title":"Case Rep Hematol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e318223fe9b","article-title":"Presentation and outcomes for children with bone marrow necrosis and acute lymphoblastic leukemia: a literature review","volume":"33","author":"Shah","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/1752-1947-6-349","article-title":"Precursor T-cell acute lymphoblastic leukemia presenting with bone marrow necrosis: a case report","volume":"6","author":"Khoshnaw","year":"2012","journal-title":"J Med Case Rep"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1737632\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T05:14:42Z","timestamp":1769058882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1737632\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":22,"alternative-id":["10.3389\/fonc.2026.1737632"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1737632","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"article-number":"1737632"}}